Ultrasound-Specific Augmentation for Enhanced Segmentation of Ovarian Tumors in B-Mode and Contrast-Enhanced Ultrasound Images
By
Yini Wang
Luyu Hu
Zebin Xue
Qinzi Li
Jingze Li
Xiaoxia Kong
July 13, 2026
Clinical Scorecard: Ultrasound-Specific Augmentation for Enhanced Segmentation of Ovarian Tumors in B-Mode and Contrast-Enhanced Ultrasound Images
At a Glance
Category Detail
Condition Ovarian Tumors Key Mechanisms Ultrasound-specific augmentation for improved segmentation robustness Target Population Patients with adnexal masses requiring ultrasound assessment Care Setting Clinical imaging and diagnostic settings
Key Highlights
Combined augmentation improved segmentation metrics for contrast-enhanced ultrasound. Dice coefficient for CEUS improved from 0.468 to 0.476. 62.9% of cases showed improvement in segmentation performance. The proportion of CEUS cases with Dice below 0.5 decreased from 55.9% to 51.8%. Training-only augmentation strategy supports modality-shift robustness. Guideline-Based Recommendations
Diagnosis
Utilize standardized terminology and structured ultrasound features for adnexal masses. Management
Incorporate segmentation models to support size measurement and shape analysis. Monitoring & Follow-up
Evaluate segmentation performance across different ultrasound modes. Risks
Segmentation models may learn appearance patterns specific to acquisition settings. Patient & Prescribing Data
Patients undergoing ultrasound evaluation for ovarian tumors.
Segmentation aids in risk assessment and treatment planning.
Clinical Best Practices
Implement ultrasound-specific augmentation to enhance segmentation robustness. Ensure consistent visual interpretation and reproducible feature extraction. Related Resources & Content
